Table 2. Univariate analysis of 2-year DFS and OS based on pathological factors in early-stage SCCC.

	Cases	2-years DFS (%)	p-value	2-years OS (%)	p-value
Age			0.659		0.742
<40 years	20	62.3		64.8
≥40 years	17	51.5		56.4
Tumor homology			0.452		0.812
Smiple SCC	28	54.3		56.9
Mixed SCC	9	59.0		63.7
FIGO stage			0.01		0.04
≤IB1	21	73.2		78.2
≥IB2	16	21.5		38.5
Tumor size (cm)			0.01		0.07
<4	24	66.1		67.6
≥4	13	0		33.3
Pelvic/para-aortic LNM			0.874		0.812
Yes	19	58.9		63.8
no	18	52.6		54.2
LVSI			0.158		0.231
Yes	23	49.5		51.4
no	14	72.4		75.5
DSI			0.095		0.153
Yes	27	46.8		49.1
no	10	68.2		70.2
Preoperative chemotherapy			0.064		0.162
Yes	11	32.8		36.5
no	16	72.1		73.4
Postoperative chemotherapy			0.815		0.856
Cisplatin/Carboplatin+Etoposide	26	55.2		55.9
Cisplatin/Carboplatin+Paclitaxel	11	59.2		64.2
Postoperative radiotherapy			0.158		0.174
Yes	15	48.2		49.1
no	22	67.3		70.3